Volume

Implications of diameter and volume-based measurement in assessment criteria for liver transplantation for hepatocellular carcinoma

Immunological characterization of hepatocellular carcinoma

Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection

Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers

Statistical strategies for HCC risk prediction models in patients with chronic hepatitis B

Prevention of hepatitis B virus-related hepatocellular carcinoma

Feasibility of totally laparoscopic hemi-hepatectomies for liver tumor, with consideration of correspondence for difficult cases

The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma

Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma

Revisiting the role of the hepatic vein in laparoscopic liver resection

Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?

Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease

Liver regeneration: metabolic and epigenetic regulation

Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Earliest hepatitis B virus-hepatocyte genome integration: sites, mechanism, and significance in carcinogenesis

Optimize nucleot(s)ide analogues’ to prevent hepatocellular carcinoma in patients with chronic hepatitis B: a lesson from real-world evidence

From PVE to HVE to fully laparoscopic rescue ALPPS: a case report of multidisciplinary management of giant HCC

Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma

Patient and port positioning in laparoscopic liver resections

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

Systematic review of existing guidelines for NAFLD assessment

Laparoscopic ICG-guided RALPPS procedure for HCC on cirrhosis with 3D reconstruction implementation: a case report

Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease

The evolution of minimally invasive surgery in liver transplantation for hepatocellular carcinoma

Prospects for a better diagnosis and prognosis of NAFLD: a pathologist´s view

Coffee and hepatocellular carcinoma: epidemiologic evidence and biologic mechanisms

Laparoscopic isolated caudate lobectomy for HCC

The impact of rituximab prophylaxis on hepatocellular carcinoma recurrence after living donor liver transplantation

The narrow ridge from liver damage to hepatocarcinogenesis

GNMT: a multifaceted suppressor of hepatocarcinogenesis

Systemic therapies for hepatocellular carcinoma: an evolving landscape

Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease

Extrahepatic cancer risk after liver transplantation for hepatocellular carcinoma: incidence, risk and prevention

Prevention of hepatitis B virus recurrence

Steatohepatitic hepatocellular carcinoma

Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa

Contribution of C3G and other GEFs to liver cancer development and progression

Defining the role of laparoscopic liver resection in elderly HCC patients: a propensity score matched analysis

Role of CD4<sup>+ </sup>T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

The prognostic evaluation of marginal positive resection in hepatoblastoma: Japanese experience

Surgical perspective on treatment of pediatric undifferentiated sarcoma of the liver

Bridging molecular basis, prognosis, and treatment of pediatric liver tumors

Preoperative planning in paediatric liver tumour surgery - a literature review

Immune checkpoint inhibitors in liver transplant recipients - a review of current literature

Neoplastic risk for liver and colon in primary sclerosing cholangitis

Involvement of DNA methylation in tissue regeneration upon liver injury

Autoimmune liver diseases, hepatocellular carcinoma, and recurrence of autoimmunity post-liver transplantation

The future of pediatric hepatocellular carcinoma: a combination of surgical, locoregional, and targeted therapy

From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: more than a single-letter change in an acronym

HCC in metabolic syndrome: current concepts and future directions

Evaluation of liver function before and during therapy

Risk factors and management of post-liver transplant recurrence of hepatocellular carcinoma

Effect of mesenchymal stem cell in liver regeneration and clinical applications

A practical approach to pediatric liver transplantation in hepatoblastoma and hepatocellular carcinoma

3D Organoid modelling of hepatoblast-like and mesenchymal-like hepatocellular carcinoma cell lines

Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study

BOOST: a phase 3 trial of sorafenib <i>vs</i>. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function

Non-invasive detection of liver cirrhosis - the “Essen algorithm”

Racial difference of mutational signature in hepatocellular carcinoma

Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor

Management of future liver remnant: strategies to promote hepatic hypertrophy

Epigenetics in hepatoblastoma

Anatomic <i>vs</i>. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises?

Neoadjuvant and adjuvant systemic treatment for hepatocellular carcinoma

Adjuvant treatment of hepatocellular carcinoma after resection

C-kit expression in cancer cells or hematopoietic cells of the tumoral microenvironment: which is the basis for efficacy of TK inhibitors and immunotherapy in HCC?

The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD

A review of current adjuvant and neoadjuvant systemic treatments for cholangiocarcinoma and gallbladder carcinoma

Use of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B

Pathology and molecular pathology of cholangiocarcinoma

Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes

Surgical management of cholangiocarcinoma

Hepatocellular carcinoma in transfusion dependent thalassemia patients: a review from a clinical perspective

Treatment of advanced biliary tract cancers: from chemotherapy to targeted agents

Clinicoradiographic predictors of progression of an intermediate hepatic lesion (LI-RADS 3) to hepatocellular carcinoma (LI-RADS 5)

Actions for 0 selected articles

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/